Novartis AG Commercial Papers Issued
Novartis AG (NVS) had Commercial Papers Issued of $4.04 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CommercialPapersIssued · last filed 2026-02-04
- 2025-12-31: Commercial Papers Issued $4.04B.
- 2024-12-31: Commercial Papers Issued $4.09B.
- 2023-12-31: Commercial Papers Issued $3.27B.
- 2022-12-31: Commercial Papers Issued $2.77B.
| Period end | Commercial Papers Issued |
|---|---|
| 2025-12-31 | $4.04B 20-F · filed 2026-02-04 |
| 2024-12-31 | $4.09B 20-F · filed 2026-02-04 |
| 2023-12-31 | $3.27B 20-F · filed 2025-01-31 |
| 2022-12-31 | $2.77B 20-F · filed 2024-01-31 |
| 2021-12-31 | $893.00M 20-F/A · filed 2023-05-15 |
| 2020-12-31 | $4.26B 20-F · filed 2022-02-02 |
| 2019-12-31 | $2.29B 20-F · filed 2021-01-26 |
| 2018-12-31 | $3.95B 20-F · filed 2020-01-29 |
| 2017-12-31 | $2.33B 20-F · filed 2019-01-30 |
| 2016-12-31 | $3.17B 6-K · filed 2018-01-24 |